Structure-Activity Relationships of Pyrimidine Derivatives and their Biological Activity - A Review. 2022

Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, The Tamil Nadu Dr. M.G.R Medical University, Chennai, Tamil Nadu, India.

BACKGROUND Heterocycles play a major role in many fields of biochemical and physiological such as amino acids, DNA bases, vitamins, endogenous neurotransmitters, etc. Nitrogencontaining heterocyclic compounds play a vital role in medicinal chemistry and exhibit notable biological and pharmacological activities. In the past two decades, scientists focused more on the diverse biological activities of pyrimidine derivatives. Pyrimidine is a six-membered heterocyclic compound, and it is present naturally in nucleic acid components (uracil, thymine, and cytosine) and vitamin B1; it is a promising lead molecule for synthesising compounds with various substitutions to treat various diseases. OBJECTIVE We focused on the structure-activity relationship of pyrimidine derivatives and its various biological activities reported from 2010 to date. RESULTS From this review, we concluded that the position of substituents in the pyrimidine nucleus greatly influences biological activities. Thus, the pyrimidine nucleus showed anti-microbial, anticancer, anti-inflammatory, anti-tubercular, anti-convulsant, antihypertensive, anthelmintic, antidepressant, analgesic, anti-hyperglycemic activities, etc. Conclusion: This study provides an overview of the pyrimidine nucleus and its derivatives from 2010 to date. There is a future scope for identifying a lead molecule for the target biological activity.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
May 2024, Phytochemistry,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
March 1998, Planta medica,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
April 1989, Bollettino della Societa italiana di biologia sperimentale,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
September 1968, The Journal of antibiotics,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
February 1967, Archives internationales de pharmacodynamie et de therapie,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
September 1996, Bollettino chimico farmaceutico,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
January 2021, Frontiers in pharmacology,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
January 2024, Mini reviews in medicinal chemistry,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
December 2023, Chemistry & biodiversity,
Ramalakshmi Natarajan, and Helina Navis Anthoni Samy, and Amuthalakshmi Sivaperuman, and Arunkumar Subramani
January 1994, Folia microbiologica,
Copied contents to your clipboard!